We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says Cancer Increase Unlikely From Vytorin, Zetia
FDA Says Cancer Increase Unlikely From Vytorin, Zetia
December 30, 2009
Merck’s cholesterol drugs Vytorin and Zetia aren’t likely to increase the risk of cancer or related deaths, according to an FDA review of data from three clinical trials.